A meta-analysis of 115 studies found sulfonylureas to be linked with higher mortality [123], while retrospective analyses suggest insulin use in HF patients with type 2 DM (T2DM) correlates with worse outcomes, though randomized controlled trials (RCTs) have not confirmed this association [124]. The gene discussed is INS; the disease is type 2 diabetes mellitus.